Notably, Kaplan–Meier survival analysis found that low ROR1 expression was significantly associated with poor patient prognosis, a result that is contrary to most studies that have partially demonstrated poor prognosis in patients with high ROR1 expression, such as ovarian cancer (43), colorectal cancer (44), and so on. This evidence concerns the gene ROR1 and ovarian carcinoma.